Tag: UCART19 Lymphoblastic Leukemia Drug
Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug
The US Food and Drug Administration (FDA) has given the green signal to Servier and Pfizer to carry out the clinical development of their UCART19 ... Read More